SAN DIEGO--(BUSINESS WIRE)--Bio-Matrix Scientific Group Inc. (OTCBB:BMSN), a biotechnology company focused on stem cell cryogenics and disposable stem cell / tissue transfer instruments, announced today that the new Class 10,000 Processing Laboratory is now 95% completed, with 100% completion scheduled by mid-October. Validation of the new Class 10,000 Processing Laboratory is scheduled to begin on October 16th.
